Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today announced the expansion of its Scientific Advisory Board to ...

The Interleukin-2 (IL-2) market is witnessing rapid growth due to advancements in cancer immunotherapy and autoimmune disease management. IL-2, a vital cytokine, promotes T-cell growth, with therapies ...

Hospital for Special Surgery (HSS) presented a research study at the European Alliance of Associations for Rheumatology ...

Camping bliss is telling ghost stories around a crackling fire as loons call in the distance. Waking up with the birds to ...

Brian Wilson, the Beach Boys' visionary and fragile leader who helped compose and arrange 'Good Vibrations,' 'California ...

The vibrant community of SLE extends beyond just its conversational frosh, writes Sherry Xie. It includes dedicated section leaders, guest lecturers, program alums, community connections and ...

The terms "disease," "disorder," "condition," and "syndrome ... Understanding the Differences Between These Common Medical Terms. By Cory Martin. Updated on November 13, 2023. ... A systemic ...

There are very few articles in the medical literature that deal with these issues (3-8,12-14,25-27), and the majority focus on the incidence of ovarian failure after cyclophosphamide use. The present ...

In terms of biochemical markers, complement (C) 3 levels increased from 0.63 ± 0.26 g/L at baseline to 0.94 ± 0.21 g/L at 52 weeks, while C4 levels rose from 0.11 ± 0.07 g/L to 0.20 ± 0.08 g/L. The ...

H istorically, medical research has been male-dominated in terms of subjects as well as researchers, even though women make up half of the world’s population. As a result of this gender bias ...

In terms of serologic testing, antiphospholipid antibodies and NMOSD antibodies should also be checked, as they have important implications for management. After excluding infections and other ...